Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sylvain Couty, Isaac M. Westwood, Andrew Kalusa, Celine Cano, Jon Travers, Kathy Boxall, Chiau Ling Chow, Sam Burns, Jessica Schmitt, Lisa Pickard, Caterina Barillari, P. Craig McAndrew, Paul A. Clarke, Spiros Linardopoulos, Roger J. Griffin, G. Wynne Aherne, Florence I. Raynaud, Paul Workman, Keith Jones, Rob L.M. van Montfort
Published Aug 25, 2013 · Vol. 4, No. 10 · pp. 1647-1661
Keywords: S6 kinase, P70S6K, cancer, inhibitor, structure-based drug design
Olga Catalina-Rodriguez, Vamsi K. Kolukula, York Tomita, Anju Preet, Ferdinando Palmieri, Anton Wellstein, Stephen Byers, Amato J. Giaccia, Eric Glasgow, Chris Albanese, Maria Laura Avantaggiati
Published Oct 20, 2012 · Vol. 3, No. 10 · pp. 1220-1235